$HBIO
HARVARD BIOSCIENCE INC

2013 Q2 Form 10-Q Financial Statement

#000117184314003812 Filed on August 07, 2014

View on sec.gov

Income Statement

Concept 2013 Q2
Revenue $26.09M
YoY Change -8.43%
Cost Of Revenue $14.01M
YoY Change -6.01%
Gross Profit $12.09M
YoY Change -11.08%
Gross Profit Margin 46.33%
Selling, General & Admin $8.752M
YoY Change -9.26%
% of Gross Profit 72.4%
Research & Development $922.0K
YoY Change -53.25%
% of Gross Profit 7.63%
Depreciation & Amortization $1.000M
YoY Change -4.76%
% of Gross Profit 8.27%
Operating Expenses $11.34M
YoY Change 2.0%
Operating Profit $746.0K
YoY Change -69.85%
Interest Expense $245.0K
YoY Change 61.18%
% of Operating Profit 32.84%
Other Income/Expense, Net -$330.0K
YoY Change 46.02%
Pretax Income $416.0K
YoY Change -81.49%
Income Tax $321.0K
% Of Pretax Income 77.16%
Net Earnings -$186.0K
YoY Change -124.03%
Net Earnings / Revenue -0.71%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$0.01
COMMON SHARES
Basic Shares Outstanding 30.10M shares
Diluted Shares Outstanding 31.70M shares

Balance Sheet

Concept 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $34.10M
YoY Change 82.35%
Cash & Equivalents $36.93M
Short-Term Investments
Other Short-Term Assets $1.500M
YoY Change -48.4%
Inventory $18.30M
Prepaid Expenses
Receivables $13.80M
Other Receivables $5.100M
Total Short-Term Assets $72.80M
YoY Change 24.86%
LONG-TERM ASSETS
Property, Plant & Equipment $4.400M
YoY Change 16.46%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $12.40M
YoY Change 11172.73%
Total Long-Term Assets $73.20M
YoY Change 2.77%
TOTAL ASSETS
Total Short-Term Assets $72.80M
Total Long-Term Assets $73.20M
Total Assets $146.0M
YoY Change 12.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.900M
YoY Change 6.36%
Accrued Expenses $3.800M
YoY Change 23.02%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $3.000M
YoY Change
Total Short-Term Liabilities $13.30M
YoY Change 34.17%
LONG-TERM LIABILITIES
Long-Term Debt $21.30M
YoY Change 32.3%
Other Long-Term Liabilities $5.800M
YoY Change 20.83%
Total Long-Term Liabilities $27.10M
YoY Change 68.32%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.30M
Total Long-Term Liabilities $27.10M
Total Liabilities $40.70M
YoY Change 29.14%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $105.4M
YoY Change
Total Liabilities & Shareholders Equity $146.0M
YoY Change 12.71%

Cashflow Statement

Concept 2013 Q2
OPERATING ACTIVITIES
Net Income -$186.0K
YoY Change -124.03%
Depreciation, Depletion And Amortization $1.000M
YoY Change -4.76%
Cash From Operating Activities $800.0K
YoY Change -68.5%
INVESTING ACTIVITIES
Capital Expenditures -$290.0K
YoY Change -6.45%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$290.0K
YoY Change -63.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.700M
YoY Change -1801.75%
NET CHANGE
Cash From Operating Activities 800.0K
Cash From Investing Activities -290.0K
Cash From Financing Activities 9.700M
Net Change In Cash 10.21M
YoY Change 772.65%
FREE CASH FLOW
Cash From Operating Activities $800.0K
Capital Expenditures -$290.0K
Free Cash Flow $1.090M
YoY Change -61.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
4.36
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-69000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
15000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1301000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-7000 USD
CY2013Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4393000 USD
CY2013Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
676000 USD
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-69000 USD
CY2013Q2 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
10000 USD
CY2014Q2 us-gaap Assets Held For Sale Current
AssetsHeldForSaleCurrent
331000 USD
CY2013Q4 us-gaap Assets Held For Sale Current
AssetsHeldForSaleCurrent
0 USD
CY2014Q2 us-gaap Other General Expense
OtherGeneralExpense
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
750000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
396000 USD
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
19000 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
919000 USD
CY2014Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
227000 USD
CY2014Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
167000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
281000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1270000 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
248000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1022000 USD
CY2014Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
1022000 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.03
CY2014Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2014Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.03
CY2014Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
322000 USD
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
747000 USD
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-329000 USD
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-186000 USD
CY2013Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-25000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
922000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
96000 USD
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2013Q2 us-gaap Other General Expense
OtherGeneralExpense
1016000 USD
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4359000 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
245000 USD
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-282000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.00
CY2013Q2 us-gaap Restructuring Charges
RestructuringCharges
-24000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.00
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
418000 USD
CY2013Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14005000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
12089000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
11342000 USD
CY2013Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
193000 USD
CY2014Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
369000 USD
CY2014Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-56000 USD
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-53000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-7000 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-34000 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
885000 USD
us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
400000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-39000 USD
us-gaap Revenues
Revenues
52851000 USD
us-gaap Revenues
Revenues
52181000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28812000 USD
us-gaap Gross Profit
GrossProfit
24039000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8989000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8248000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2257000 USD
us-gaap Restructuring Charges
RestructuringCharges
252000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1221000 USD
us-gaap Other General Expense
OtherGeneralExpense
0 USD
us-gaap Operating Expenses
OperatingExpenses
20967000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
3072000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-148000 USD
us-gaap Interest Expense
InterestExpense
513000 USD
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
26000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-148000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-783000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2289000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
548000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1741000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
us-gaap Net Income Loss
NetIncomeLoss
1741000 USD
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.05
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.05
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
584000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-80000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Interest Expense
InterestExpense
374000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
2072000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-427000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8581000 USD
us-gaap Net Income Loss
NetIncomeLoss
-92000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1844000 USD
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.03
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.03
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.03
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.03
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
620000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1982000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-81000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-53000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
27831000 USD
us-gaap Restructuring Charges
RestructuringCharges
-45000 USD
us-gaap Operating Expenses
OperatingExpenses
22278000 USD
us-gaap Gross Profit
GrossProfit
24350000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1935000 USD
us-gaap Other General Expense
OtherGeneralExpense
1520000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1355000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1645000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
9000 USD
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
374000 USD
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
246000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8932000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
484000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
0 USD
CY2014Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
484000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
0 USD
us-gaap Depreciation
Depreciation
608000 USD
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
0 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4000 USD
hbio Non Cash Restructuring Charge
NonCashRestructuringCharge
-118000 USD
hbio Amortization Of Catalog Costs
AmortizationOfCatalogCosts
24000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-30000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
30000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
119000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
294000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1312000 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
864000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
349000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
51000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-36000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-7000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
89000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2486000 USD
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
-744000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
78000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-666000 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2500000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1001000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1499000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
342000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
663000 USD
us-gaap Interest Paid
InterestPaid
458000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
688000 USD
hbio Amortization Of Catalog Costs
AmortizationOfCatalogCosts
56000 USD
us-gaap Depreciation
Depreciation
662000 USD
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
339000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-1000 USD
hbio Non Cash Restructuring Charge
NonCashRestructuringCharge
-44000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
42000 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1237000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
287000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-265000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
267000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
932000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-3000 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
773000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1380000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20681000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34098000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
13417000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-622000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
1006000 USD
us-gaap Interest Paid
InterestPaid
272000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13298000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1999000 USD
CY2013Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
300000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
800000 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
12049000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3000 USD
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
-585000 USD
hbio Additions To Catalog Costs
AdditionsToCatalogCosts
-57000 USD
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<p style='margin-top:9pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;">2</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">.</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Recently Issued Accounting Pronouncements</font></p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:11pt;font-weight:bold;margin-left:0px;"> </font></p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:24.5px;">In May 2014, the Financial Ac</font><font style="font-family:Times New Roman;font-size:10pt;">counting Standards Board (FASB) </font><font style="font-family:Times New Roman;font-size:10pt;">issued </font><font style="font-family:Times New Roman;font-size:10pt;">Accounting Standards Update (ASU) 2014-09, </font><font style="font-family:Times New Roman;font-size:10pt;font-style:italic;">&#8220;Revenue from Contracts with Customers,&#8221;</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">a new accounting standard that provides for a comprehensive model to use in the accounting for revenue arising from contracts with customers that will replace most existing revenue recognition guidance in U.S. </font><font style="font-family:Times New Roman;font-size:10pt;">GAAP</font><font style="font-family:Times New Roman;font-size:10pt;">. Under this standard, revenue will be recognized to depict the transfer of promised goods</font><font style="font-family:Times New Roman;font-size:10pt;"> or services to customers in an amount that reflects </font><font style="font-family:Times New Roman;font-size:10pt;">the consideration to which the C</font><font style="font-family:Times New Roman;font-size:10pt;">ompany expects to be entitled in exchange for those goods or services. This standard will be effective as of the beginning of the Company's 2017 fiscal year. The </font><font style="font-family:Times New Roman;font-size:10pt;">C</font><font style="font-family:Times New Roman;font-size:10pt;">ompany is assessing the new standard and has not yet determined the impact to the consolidated financial statements. </font><font style="font-family:Times New Roman;font-size:10pt;"> </font></p><p style='margin-top:9pt; margin-bottom:0pt'>&#160;</p>
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
20000 USD
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
69000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
89000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
41715000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-24036000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
41740000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-22731000 USD
CY2014Q2 hbio Total Indefinite Lived Intangible Assets Including Goodwill
TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill
38126000 USD
CY2013Q4 hbio Total Indefinite Lived Intangible Assets Including Goodwill
TotalIndefiniteLivedIntangibleAssetsIncludingGoodwill
37894000 USD
CY2013Q4 hbio Total Intangible Assets
TotalIntangibleAssets
79634000 USD
CY2014Q2 hbio Total Intangible Assets
TotalIntangibleAssets
79841000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
234000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1700000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1800000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2100000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2200000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2500000 USD
CY2014Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8396000 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
7039000 USD
CY2014Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
663000 USD
CY2013Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
752000 USD
CY2014Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
8152000 USD
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
7986000 USD
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
19133000 USD
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15005000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18820000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14445000 USD
CY2013Q4 hbio Date Separation Plan Completed
DateSeparationPlanCompleted
November 1, 2013
CY2013Q4 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2013-10-21
CY2013Q4 hbio Spinoff Distribution Ratio
SpinoffDistributionRatio
1 for 4
CY2013Q4 hbio Date Entered Into Commerical Agreements With Spinnee
DateEnteredIntoCommericalAgreementsWithSpinnee
31-Oct-13
CY2013Q4 hbio Lost Value Adjustment To Share And Exercise Price Of Existing Options
LostValueAdjustmentToShareAndExercisePriceOfExistingOptions
0.8
CY2013Q4 hbio Percent Lost Value Provided Back To Option Holder
PercentLostValueProvidedBackToOptionHolder
0.2
CY2013Q4 hbio Lost Value Adjustment To Share Amount Of Existing Outstanding Restricted Stock Units
LostValueAdjustmentToShareAmountOfExistingOutstandingRestrictedStockUnits
0.8
CY2013Q4 hbio Percent Lost Value Provided Back To Restricted Stock Unit Holder
PercentLostValueProvidedBackToRestrictedStockUnitHolder
0.2
CY2013Q4 hbio Asset Transfer As Part Of Spinoff
AssetTransferAsPartOfSpinoff
900000 USD
CY2013Q1 hbio Date Private Letter Ruling
DatePrivateLetterRuling
22-Mar-13
CY2013Q2 hbio Date Supplemental Ruling To Private Letter Ruling
DateSupplementalRulingToPrivateLetterRuling
28-Jun-13
CY2013Q4 hbio Taxable Spinoff From Percent Acquired Stock
TaxableSpinoffFromPercentAcquiredStock
0.5
CY2013Q4 hbio Transfer Of Cash And Cash Equivalents To Hart
TransferOfCashAndCashEquivalentsToHART
15000000 USD
CY2013Q4 hbio Incremental Options Granted Due To Hart Spinoff
IncrementalOptionsGrantedDueToHartSpinoff
1700000 shares
CY2013Q4 hbio Incremental Units Granted Due To Hart Spinoff
IncrementalUnitsGrantedDueToHartSpinoff
100000 shares
CY2014Q2 hbio Transition Services Charged To Spinnee
TransitionServicesChargedToSpinnee
41000 USD
CY2014Q2 hbio Distribution Revenues From Spinnee
DistributionRevenuesFromSpinnee
31000 USD
CY2014Q2 us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
41000 USD
hbio Transition Services Charged To Spinnee
TransitionServicesChargedToSpinnee
101000 USD
us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
81000 USD
hbio Distribution Revenues From Spinnee
DistributionRevenuesFromSpinnee
109000 USD
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
-51000 USD
CY2013 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
-179000 USD
CY2013 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
262000 USD
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
24000 USD
CY2014Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
278000 USD
CY2013Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
305000 USD
CY2012Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
222000 USD
CY2014Q2 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
-8000 USD
CY2013Q2 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
77000 USD
CY2013Q2 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
190000 USD
CY2013Q2 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
125000 USD
CY2013Q2 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-59000 USD
CY2014Q2 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-46000 USD
CY2014Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
98000 USD
CY2013Q2 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
201000 USD
CY2014Q2 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
0 USD
CY2013Q2 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
0 USD
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
0 USD
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
151000 USD
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
448000 USD
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
330000 USD
us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-91000 USD
us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-116000 USD
us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
0 USD
us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
0 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
209000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
395000 USD
us-gaap Defined Benefit Plans Estimated Future Employer Contributions In Current Fiscal Year
DefinedBenefitPlansEstimatedFutureEmployerContributionsInCurrentFiscalYear
400000 USD
CY2014Q2 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
200000 USD
CY2013Q2 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
200000 USD
CY2014Q2 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
5600000 USD
CY2013Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
4900000 USD
us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
500000 USD
hbio Defined Benefit Plan Unrealized Loss Gain
DefinedBenefitPlanUnrealizedLossGain
600000 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1824000 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1305000 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1322000 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1304000 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1182000 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
4973000 USD
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
11910000 USD
CY2014Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
400000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
600000 USD
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2024-08-31
CY2014Q2 hbio Expansion Area Of Real Estate Property
ExpansionAreaOfRealEstateProperty
22000
CY2014Q2 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
83000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
974500 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.13
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
-759652 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
4.78
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6690845 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6510633 shares
CY2013Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
3.42
CY2014Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
3.38
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
306397 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.13
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
463973 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
-233098 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.32
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.30
hbio Stock Issued During Period Gross Stock Options Exercised
StockIssuedDuringPeriodGrossStockOptionsExercised
395060 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
-40878 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
116400 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.12
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
558456 shares
CY2014Q2 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
31116 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5716
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0180
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M14D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.572
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.572
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5683
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0178
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0118 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0118
CY2013Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y7M20D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M0D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y7M20D
CY2014Q2 us-gaap Share Based Compensation
ShareBasedCompensation
472000 USD
CY2013Q2 us-gaap Share Based Compensation
ShareBasedCompensation
588000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1237000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
919000 USD
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30102691 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32045314 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31695238 shares
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32945932 shares
CY2014Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
900618 shares
CY2013Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1592547 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31946654 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29941294 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1738970 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
988801 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32935455 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31680264 shares
CY2014Q2 hbio Percentage Of Outstanding Common Stock
PercentageOfOutstandingCommonStock
0.20
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Discount From Market Price Offering Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate
0.85
CY2014Q2 hbio Employee Stock Purchase Plan Shares Authorized
EmployeeStockPurchasePlanSharesAuthorized
750000 shares
CY2014Q2 us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
-34000 USD
CY2014Q2 hbio Minimun Percentage Of Term Loan And Delayed Draw Term Loan On Which Interest Rate Required To Be Fixed
MinimunPercentageOfTermLoanAndDelayedDrawTermLoanOnWhichInterestRateRequiredToBeFixed
0.5
CY2013Q4 hbio Transferof Delayed Draw Down Term Loan Capacity To Revolver Capacity
TransferofDelayedDrawDownTermLoanCapacityToRevolverCapacity
5000000 USD
CY2013Q2 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
27305 shares
hbio Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
2.19
CY2014Q2 hbio Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
2.20
CY2013Q2 hbio Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
2.64
hbio Weighted Average Estimated Black Scholes Value Of Option Grants
WeightedAverageEstimatedBlackScholesValueOfOptionGrants
2.64
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2464906 shares
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2477884 shares
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2724220 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2578743 shares
CY2013Q4 us-gaap Secured Debt
SecuredDebt
24750000 USD
CY2014Q2 us-gaap Secured Debt
SecuredDebt
22250000 USD
CY2014Q2 hbio Lender Approval To Fund Acquisition With Cash Promissory Note In Excess Of Threshold
LenderApprovalToFundAcquisitionWithCashPromissoryNoteInExcessOfThreshold
6000000 USD
CY2014Q2 hbio Lender Approval To Fund Acquisition With Equity In Excess Of Threshold
LenderApprovalToFundAcquisitionWithEquityInExcessOfThreshold
10000000 USD
CY2009Q3 hbio Previous Approved Credit Facility
PreviousApprovedCreditFacility
20000000 USD
CY2013Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
50000000 USD
CY2013Q1 hbio Ddtl Threshold For Dollar For Dollar Reduction In Revolving Line
DdtlThresholdForDollarForDollarReductionInRevolvingLine
10000000 USD
CY2009Q3 hbio Interest Rate In Excess Of Libor On Credit Facility
InterestRateInExcessOfLiborOnCreditFacility
0.03
CY2014Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
21600000 USD
CY2014Q2 us-gaap Derivative Asset Notional Amount
DerivativeAssetNotionalAmount
15500000 USD
CY2013Q4 invest Derivative Notional Amount
DerivativeNotionalAmount
17500000 USD
CY2013Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
-49000 USD
us-gaap Derivative Instruments Loss Recognized In Other Comprehensive Income Effective Portion
DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion
-80000 USD
CY2014Q2 us-gaap Derivative Instruments Loss Recognized In Other Comprehensive Income Effective Portion
DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion
-56000 USD
CY2013Q2 us-gaap Derivative Instruments Loss Recognized In Other Comprehensive Income Effective Portion
DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion
-53000 USD
us-gaap Derivative Instruments Loss Recognized In Other Comprehensive Income Effective Portion
DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion
-53000 USD
us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
-7000 USD
us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
-69000 USD
CY2013Q2 us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
-7000 USD
CY2014Q2 us-gaap Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimated Net Amount To Be Transferred
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
100000 USD
CY2014Q2 hbio Derivative Interest Rate Swap Effective Percentage
DerivativeInterestRateSwapEffectivePercentage
1
CY2014Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.195
CY2013Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.77
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.239
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.377

Files In Submission

Name View Source Status
0001171843-14-003812-index-headers.html Edgar Link pending
0001171843-14-003812-index.html Edgar Link pending
0001171843-14-003812.txt Edgar Link pending
0001171843-14-003812-xbrl.zip Edgar Link pending
exh101_1.jpg Edgar Link pending
exh101_2.jpg Edgar Link pending
exh101_3.jpg Edgar Link pending
exh101_4.jpg Edgar Link pending
exh101_5.jpg Edgar Link pending
exh101_6.jpg Edgar Link pending
exh_101.htm Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
exh_322.htm Edgar Link pending
f10q_080714.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hbio-20140630.xml Edgar Link completed
hbio-20140630.xsd Edgar Link pending
hbio-20140630_cal.xml Edgar Link unprocessable
hbio-20140630_def.xml Edgar Link unprocessable
hbio-20140630_lab.xml Edgar Link unprocessable
hbio-20140630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending